EQAs for SARS-Cov-2 and other respiratory viruses open for registration
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
2021 EQA schemes open for registration
We are delivering 90 different EQA schemes covering 8 different core areas of genomics:
- Molecular genetics
- Molecular pathology (including FFPE and plasma based testing)
- Pharmacogenetics
- Technology (e.g NGS)
- Prenatal and Postnatal testing
- Virology
- Interlaboratory Comparisons (sample exchanges).
To browse our catalogue, or download a copy of the participant guide, please follow the link below.
We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
The latest news and press releases
Validated genotypes published today for 2021 Germline EQA schemes - https://t.co/kezRu0jz1s
Invitation to a live webinar: lessons learned from the 2020 ovarian and prostate cancer EQA schemes - click here to… https://t.co/U72Bgpo0xE
FINAL results from 2020 Molecular Pathology EQA schemes published to users EMQN website accounts today - https://t.co/2jkOlTJ73X
Reminder - deadline rapidly approaching for submitting results for 2021 Germline EQA schemes - https://t.co/nAxR6qFyMs
FINAL results from 2020 Non-invasive prenatal testing (NIPT) EQA schemes published today. Please login to your EMQN… https://t.co/dcM3OgtLxi